Last year’s Q3 profits were dented by a Rs 46 crore ‘mark to market’ loss on foreign exchange exposure of the company. Adjusted for this exceptional item, Biocon’s profits at Rs 81 crore was 9 per cent higher in the December 2009 quarter.
The company reported a total income of Rs 642 crore in the December 2009 quarter, up 42 per cent from last year.
Published 21 January 2010, 11:38 IST